A novel class of Ribosome Modulating Agents (RMAs) targets ribosome heterogeneity in a subset of colorectal cancers

V. Badarinarayana, E. Terzo, S. Apte, S. Padhye, S. Rashed, W. Austin, M. Caponegro, A. Reddy, C. Wang, R. Clark, D. Sidransky, V. Modur

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)S73-S74
JournalEuropean Journal of Cancer
StatePublished - Oct 2022

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this